Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer.

[1]  M. Nieto,et al.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.

[2]  Jingxuan Yang,et al.  Circulating tumor cells in the diagnosis and management of pancreatic cancer. , 2012, Biochimica et biophysica acta.

[3]  Chuanli Ren,et al.  Increased plasma microRNA and CD133/CK18-positive cancer cells in the pleural fluid of a pancreatic cancer patient with liver and pleural metastases and correlation with chemoresistance. , 2012, Oncology letters.

[4]  Tao Wang,et al.  Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer , 2012, Clinical Cancer Research.

[5]  Y. Gong,et al.  Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer , 2012, International journal of cancer.

[6]  F. Saad,et al.  The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. , 2012, Future oncology.

[7]  Maximilian Reichert,et al.  EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.

[8]  M. Bouvet,et al.  Marker expression in circulating cancer cells of pancreatic cancer patients. , 2011, The Journal of surgical research.

[9]  Xiaohang Zhao,et al.  Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy , 2011, Cancer biology & therapy.

[10]  Xiaohang Zhao,et al.  Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgery , 2011, Cancer biology & therapy.

[11]  Giuseppe Naso,et al.  Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients , 2011, Breast Cancer Research and Treatment.

[12]  Andrew Menzies,et al.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.

[13]  Jeffrey S. Morris,et al.  Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study , 2010, Clinical Cancer Research.

[14]  A. Luini,et al.  Changes in Circulating Tumor Cell Detection in Patients with Localized Breast Cancer Before and After Surgery , 2010, Annals of Surgical Oncology.

[15]  Peter Kuhn,et al.  Cytomorphology of Circulating Colorectal Tumor Cells:A Small Case Series , 2010, Journal of oncology.

[16]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[17]  R. Eils,et al.  Systemic spread is an early step in breast cancer. , 2008, Cancer cell.

[18]  S. Digumarthy,et al.  Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.

[19]  Joel G Fletcher,et al.  Resectability of Presymptomatic Pancreatic Cancer and Its Relationship to Onset of Diabetes: A Retrospective Review of CT Scans and Fasting Glucose Values Prior to Diagnosis , 2007, The American Journal of Gastroenterology.

[20]  S. Satomura,et al.  Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. , 2007, Clinica chimica acta; international journal of clinical chemistry.

[21]  H. Kalthoff,et al.  Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival , 2005, Journal of Cancer Research and Clinical Oncology.

[22]  M. Goggins Molecular markers of early pancreatic cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  N. Lane,et al.  Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. , 2005, Cytotherapy.

[24]  K. Pienta,et al.  Apoptosis of circulating tumor cells in prostate cancer patients , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[25]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[26]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[27]  Tanja Fehm,et al.  Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  E. Kubista,et al.  Circulating breast cancer cells are frequently apoptotic. , 2001, The American journal of pathology.

[29]  Rune Smaaland,et al.  Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications , 2014, International journal of cancer.

[30]  Q. Sun,et al.  CTCs hemodialysis: can it be a new therapy for breast cancer? , 2013, Medical hypotheses.

[31]  Klaus Pantel,et al.  Biologic challenges in the detection of circulating tumor cells. , 2013, Cancer research.